| HOME >> BIOLOGY >> TECHNOLOGY |
Table 49: WH Disorder Therapeutics Market, Global, R&D Pipeline by Phase in Endometriosis Market, Phase III and Regulatory Filing, August 2010 97
Table 50: WH Disorder Therapeutics Market, Global, R&D Pipeline by Phase in Endometriosis Market, Phase II Pipeline, August 2010 97
Table 51: WH Disorder Therapeutics Market, Global, R&D Pipeline by Phase in Endometriosis Market, Phase I Pipeline, August 2010 97
Table 52: WH Disorder Therapeutics Market, Global, R&D Pipeline by Phase in Endometriosis Market, Preclinical Pipeline, August 2010 97
Table 53: WH Disorder Therapeutics Market, Global, R&D Pipeline by Phase in Postmenopausal Osteoporosis Market, Phase III and Regulatory Filing, August 2010 99
Table 54: WH Disorder Therapeutics Market, Global, R&D Pipeline by Phase in Postmenopausal Osteoporosis Market, Phase II Pipeline, August 2010 99
Table 55: WH Disorder Therapeutics Market, Global, R&D Pipeline by Phase in Postmenopausal Osteoporosis Market, Phase I Pipeline, August 2010 99
Table 56: WH Disorder Therapeutics Market, Global, R&D Pipeline by Phase in Postmenopausal Osteoporosis Market, Preclinical Pipeline, August 2010 100
Table 57: WH Disorder Therapeutics Market, Global, Major M&A Deals, 2009–2010 120
1.2 List of FiguresFigure 1: Women's Health Market, Global, Drivers and Restraints, 2009 11
Figure 2: WH Disorder Therapeutics Market, Global, Sales Value ($bn), 2001–2016 12
Figure 3: WH Disorder Therapeutics Market, Global, Annual Cost of Therapy ($), 2001–2016 13
Figure 4: WH Disorder Therapeutics Market, Global, Therapeutic Usage Patterns, 2001–2016 14
Figure 5: WH Disorder Therapeutics Market, Global, Diseased Population (in millions), 2001–2016 16
Figure 6: WH Disorder Therapeutics Market, Global, Treatment Seeking Population (in millions), 2001–
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |